Published on in Vol 4 (2023)

Preprints (earlier versions) of this paper are available at https://www.medrxiv.org/content/10.1101/2021.10.22.21265316v1, first published .
The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study

The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study

The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study

Journals

  1. Mpofu R. Peer Review “The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study”. JMIRx Med 2023;4:e47143 View
  2. . Peer Review of “The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study”. JMIRx Med 2023;4:e46908 View
  3. . Peer Review of “The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study”. JMIRx Med 2023;4:e47384 View
  4. Poluru R. Peer Review of “The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study”. JMIRx Med 2023;4:e46906 View
  5. Mabuka T, Naidoo N, Ncube N, Yiga T, Ross M, Kurehwa K, Nare Nyathi M, Silaji A, Ndemera T, Lemeke T, Taiwo R, Macharia W, Sithole M. Authors’ Response to Peer Reviews of “The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study”. JMIRx Med 2023;4:e46944 View
  6. Mashamaite C, Ngcobo B, Manyevere A, Ramatsitsi M. Potential of Moringa oleifera Lam. in reducing severe symptoms of COVID-19 infection: a South African perspective. Acta Horticulturae 2024;(1394):85 View
  7. Al Akoury N, Spinardi J, Haridy H, Molefe -Osman N, Mphahlele N, Mendoza C, Yang J, Aruffo E, Kyaw M, Yarnoff B. Modeling the potential public health impact of different vaccination strategies with an adapted vaccine in South Africa. Expert Review of Vaccines 2024;23(1):750 View